Merck Animal Health has been hit with a class action lawsuit by consumers who claim that their dog and cat drug Bravecto contains a pesticide that is harmful to pets.
Bravecto tablets and topical medications are used on both cats and dogs, and are marketed as a way to prevent ticks and fleas for up to three months.
Plaintiff Valerie Palmieri says she paid just under $50 for one Bravecto chewable tablet to treat her 78 pound German Shepherd Jake for fleas and ticks.
After taking the pill, Jake started to vomit, did not eat, and began to show symptoms of lethargy, according to the Bravecto class action lawsuit. The plaintiff reportedly took Jake to the emergency animal clinic after the dog was no longer able to walk.
Palmieri claims that she contacted Merck to talk about Jake’s possible adverse reaction to taking the drug. The company allegedly denied that that Jake’s sickness was caused by Bravecto but offered to pay for the emergency room visit.
However, the company would only pay if she signed an agreement which would release any claims against the company, according to the Bravecto class action lawsuit.
The plaintiff states that she refused to release her claims as she wasn’t sure if Jake’s symptoms would be long-term and was still not sure if her dog’s symptoms were caused by the drug.
After more tests and a trip to a neurologist, the plaintiff’s veterinarian allegedly told her that he “presumed” that Jake’s diagnosis of meningitis was a result of “Bravecto toxicity,” which was contrary to what she was told by the defendant.
Since he ingested the drug, Jake has continued to have neurological episodes, according to the Bravecto class action lawsuit. In September of this year, he reportedly fell down a flight of stairs and broke his leg. The plaintiff claims that she has spent “tens of thousands of dollars” treating Jake after he ingested Bravecto.
Palmieri says that when she purchased the tablet, the packaging and materials enclosed therein did not state that neurological adverse reactions were possible when taking the pill. In addition, the defendant allegedly did not tell veterinarians about the possible safety issues that the drug posed to pets.
“Because Defendant failed to disclose the risks of Bravecto to consumers and misrepresented the safety of Bravecto, consumers would be reasonable in purchasing Bravecto to treat their pets in a safe manner,” the class action lawsuit notes.
The Bravecto class action lawsuit also states that in September 2018, the FDA issued an alert about the possible neurological events that are associated with medicines like Bravecto to treat fleas and ticks.
The FDA has subsequently asked manufacturers to change their labels to “highlight neurological events because these events were seen consistently across the isoxazoline class of products” and “to provide veterinarians and pet owners with the information they need to make treatment decisions for each pet on an individual basis,” according to the Bravecto class action lawsuit.
The plaintiff states that the defendant now discloses that there may be some neurological reactions to taking Bravecto, including tremors, ataxia, and seizures.
“Every consumer who purchased Bravecto without being informed of the true facts about its health and safety risks prior to purchase was injured at the point of sale when, instead of obtaining a safe flea and tick medication, they obtained Defendant’s unreasonably dangerous and defective product,” the Bravecto class action lawsuit states.
Did you purchase Bravecto for your pet? Leave a message in the comments section below.
The plaintiff is represented by Mark A. Dicello, Adam J. Levitt, and Amy E. Keller of DiCello Levitt and Gutzler LLC and Jessica J. Sleater and Ralph N. Sianni of Andersen Sleater Sianni LLC.
The Bravecto Class Action Lawsuit is Valerie Palmieri v. Intervet Inc., et. al, Case No. 2:19-cv-22024, in the U.S. District Court for the District of New Jersey.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
1,807 thoughts onBravecto Class Action Says Meds Aren’t Safe For Pets
Add Me Please
Cat #1 would walk a few feet & then look as though he slammed into a closed window. He did this 5-7 times every day for approximately 5 months. Cat #2 became lethargic & she died a week later. I have felt so guilty & blamed myself for their deaths. Even though I followed the instructions, I assumed that I had misjudged how much I gave them. Now I see differently.
Add me
Add me
Please add me
We gave our 13 old cat the treatment a day later he was puking , foaming at the mouth , couldn’t walk was going to take him in right away in am but he suffered all night crying couldn’t move an he passed away we have proof of that I bought for all my cats n dogs spent 770 dollars at vet unfortunately ground is hard so we have him in a box in garage frozen until spring please help I truly know this is what caused his death he was the.healthiest cat we had :(
Please add me
Add me
I gave 3 month Bravecto to my cat twice, spaced about a year apart. (8/4/18 and 10/24/19). The only reason I gave the 2nd dose was because my Vet, per the Merck Animal Health division, insisted that my cat’s symptoms which included several seizures a day were absolutely not related to Bravecto. Insisting that if the animal were to have Bravecto related seizures they would happen immediately after taking the drug, not several weeks later. The Bravecto wore off the first time and the seizures stopped (as did the other side effects listed below). Several weeks after taking the 2nd dose a year later again the seizures started again and the other side effects returned. Now that she is approaching the end of the effectiveness of the 2nd dose of Bravecto the seizures are stopping again. Her side effects are: gait issues, very very thirsty, extremely lethargic (sleeps 22 out of 24 hours), skin broke out in large itchy scabby lesions, scratches constantly or licks her fur constantly when not sleeping. Pulls out hair clumps with her teeth sometimes for hours, reduced appetite, lose weight, shortrange vision issues (?), and no longer playful. She has tremors as well, both while awake and sleeping. During the first instance I had the Vet open a case number with Merck. I never heard back from them. When the seizures started on the 2nd dose I called Merck Animal Health myself wanting to know if there is an antidote. They were closed for the week during the holidays the recording said (and no one covering). I did explain I had an open case and left the number on the voicemail. I still haven’t heard back and it is into the 2nd week after the holiday period. Since I had an open case and was again advising that the same severe reactions were occurring and was asking them for an antidote you would think they would care enough to call back. I suggest others reading this do not bother to call the Manufacturer (Merck) but the FDA as the literature says you can report side effects or concerns to either party. Merck is apparently more interested in corporate profits more than patient safety with this patented medicine and in not being interested in gaining more info so they could make their product safe (like the FDA requested they do in the September 2018 warning they received). I hope they do not have the same corporate culture when it comes to medications for human patients.
Add Me